A man who spent more than 90 days in a California hospital, almost losing his life to Covid-19, has a message for the public: get vaccinated. - nbcla
"I came back to Centinela Hospital to give thanks to God and the doctors and nurses, all the medical staff."
Even when he was discharged the battle was far from over he left in a wheelchair with a tracheostomy tube to help him breath.The 32 year old had spent two months in ICU where he had to be put in an induced coma to protect his organs.But he overcame all odds and is now on the road to a full recovery. He's gained 65 pounds, is a newlywed and has a new job."They took care of me and made sure that I would pull out of this dark situation.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
COVID-19 Cases In U.S. Triple Over 2 Weeks Amid MisinformationCOVID-19 cases have tripled in the U.S. over two weeks amid an onslaught of vaccine misinformation.
Leer más »
Cape Cod COVID-19 cluster grows to more than 130 infected, prompting renewed mitigation effortsOfficials in Provincetown, Massachusetts, issued a number of renewed mitigation measures on Monday after at least 132 individuals tested positive for COVID-19 in the weeks after the holiday weekend.
Leer más »
Why breakthrough COVID-19 infections don't mean the vaccine isn't workingBreakthrough COVID-19 cases aren't proof the vaccines aren't working, experts say, but are normal and expected.
Leer más »
South Korea logs record rise in daily Covid-19 cases - latest updatesSouth Korea logs another record rise in daily Covid-19 cases. Here are other updates: 🇵🇪 Peru arrests hospital workers over bed scam 🇦🇺 Victoria state's cases rise amid lockdowns in Australia 🇺🇸 President Biden urges vaccinations at town hall For more:
Leer más »
J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine salesJohnson & Johnson (JNJ.N) raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production and safety problems and catch up with rivals Pfizer and Moderna.
Leer más »